Skip to main content
. 2021 Mar 21;2021(3):CD012799. doi: 10.1002/14651858.CD012799.pub2

Comparison 1. SSRI versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Participant perception of change with treatment 6 3260 Risk Ratio (M‐H, Random, 95% CI) 1.92 [1.66, 2.23]
1.2 Participant satisfaction with intercourse 3 4273 Risk Ratio (M‐H, Random, 95% CI) 1.63 [1.42, 1.87]
1.3 Study withdrawal due to adverse events 20 7367 Risk Ratio (M‐H, Random, 95% CI) 3.80 [2.61, 5.51]
1.4 Perceived control over ejaculation 3 4273 Risk Ratio (M‐H, Random, 95% CI) 2.29 [1.72, 3.05]
1.5 Participant distress about PE 1 652 Risk Ratio (M‐H, Random, 95% CI) 1.54 [1.26, 1.88]
1.6 Relationship difficulties 1 652 Risk Ratio (M‐H, Random, 95% CI) 1.20 [1.07, 1.34]
1.7 Adverse events 17 4624 Risk Ratio (M‐H, Random, 95% CI) 1.71 [1.48, 1.99]
1.8 Intravaginal ejaculatory latency time 20 5872 Mean Difference (IV, Random, 95% CI) 3.09 [1.94, 4.25]
1.9 Depression 1 14 Risk Ratio (M‐H, Random, 95% CI) 2.00 [0.23, 17.34]